Development of Novel Extracellular Vesicle-Based Therapeutic Platforms for Regenerative Medicine
This grant is for developing new technologies that use extracellular vesicles for regenerative medicine. It supports work on how to produce, manufacture, and use these vesicles as treatments.
Source
Award
Dates
Eligibility
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe)
National Institutes of Health
-
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
RFA: EDS Accelerator Award
American Cancer Society
-
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers